Expert Consensus on the Characteristics of Patients with Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV + PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study.
Sridhar ChagantiArie BarlevSophie CaillardSylvain ChoquetKate CwynarskiAnke FriedetzkyEva González-BarcaNatalia SadetskyStefan SchneebergerDhanalakshmi ThirumalaiPier L ZinzaniRalf U TrappePublished in: Advances in therapy (2023)
PTLD.